Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keith

Showing results (601-610 of 918) with videos related to

Pageof 92
Sort By:
ACS Applied Materials & Interfaces|September 17, 2020
Unveiling the Synergistic Role of Oxygen Functional Groups in the Graphene-Mediated Oxidation of GlutathioneYan Wang, Yasemin Basdogan, Tianyu Zhang, et al.
British Journal of Haematology|March 16, 2004
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplantHong Chang, Stephen Sloan, Dan Li, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2008
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infectionsEarl R Kern, Mark N Prichard, Debra C Quenelle, et al.
Plant Physiology|April 1, 1990
Selection and characterization of sethoxydim- tolerant maize tissue culturesW B Parker, D A Somers, D L Wyse, et al.
Magnetic Resonance in Medicine|April 23, 2014
Optimized saturation pulse train for human first-pass myocardial perfusion imaging at 7TYuehui Tao, Aaron T Hess, Graeme A Keith, et al.
Clinical Nuclear Medicine|December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial DiagnosisSeyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
Pharmacology|December 1, 1993
ICI 206,970: a novel calcium channel blocker with eukalemic diuretic activityB B Howe, R A Keith, M L Do, et al.
British Journal of Haematology|February 12, 2004
Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myelomaJoshua L Paterson, Zhihua Li, Xiao-Yan Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myelomaDonna E Reece, Giovanni Piza Rodriguez, Christine Chen, et al.
Nature Biotechnology|May 18, 2004
Production of very long chain polyunsaturated omega-3 and omega-6 fatty acids in plantsBaoxiu Qi, Tom Fraser, Sam Mugford, et al.
Pageof 92

Showing results (601-610 of 918) with videos related to

Sort By:
Pageof 92
ACS Applied Materials & Interfaces|September 17, 2020
Unveiling the Synergistic Role of Oxygen Functional Groups in the Graphene-Mediated Oxidation of GlutathioneYan Wang, Yasemin Basdogan, Tianyu Zhang, et al.
British Journal of Haematology|March 16, 2004
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplantHong Chang, Stephen Sloan, Dan Li, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2008
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infectionsEarl R Kern, Mark N Prichard, Debra C Quenelle, et al.
Plant Physiology|April 1, 1990
Selection and characterization of sethoxydim- tolerant maize tissue culturesW B Parker, D A Somers, D L Wyse, et al.
Magnetic Resonance in Medicine|April 23, 2014
Optimized saturation pulse train for human first-pass myocardial perfusion imaging at 7TYuehui Tao, Aaron T Hess, Graeme A Keith, et al.
Clinical Nuclear Medicine|December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial DiagnosisSeyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
Pharmacology|December 1, 1993
ICI 206,970: a novel calcium channel blocker with eukalemic diuretic activityB B Howe, R A Keith, M L Do, et al.
British Journal of Haematology|February 12, 2004
Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myelomaJoshua L Paterson, Zhihua Li, Xiao-Yan Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myelomaDonna E Reece, Giovanni Piza Rodriguez, Christine Chen, et al.
Nature Biotechnology|May 18, 2004
Production of very long chain polyunsaturated omega-3 and omega-6 fatty acids in plantsBaoxiu Qi, Tom Fraser, Sam Mugford, et al.
Pageof 92